Login / Signup

Possible effectiveness of switching biologics from adalimumab to certolizumab pegol in pyoderma gangrenosum.

Minoru KimuraAkihiko UchiyamaYukie EndoMasahito YasudaSei-Ichiro Motegi
Published in: The Journal of dermatology (2024)
Keyphrases
  • randomized controlled trial
  • rheumatoid arthritis
  • systematic review
  • juvenile idiopathic arthritis
  • ulcerative colitis
  • systemic lupus erythematosus
  • disease activity